Princess of Wales Undergoes Planned Abdominal Surgery
By Ernie Mundell HealthDay Reporter
WEDNESDAY, Jan. 17, 2024 -- Kate Middleton, the Princess of Wales, has undergone a planned abdominal surgery, Kensington Palace reported Wednesday.
As reported by the BBC, the surgery was successful and the 42-year-old princess will remain in the hospital for between 10 and 14 days.
No details were provided by the palace as to the reasons for the surgery.
"Her Royal Highness The Princess of Wales was admitted to The London Clinic yesterday for planned abdominal surgery," the palace statement read. "Based on the current medical advice, she is unlikely to return to public duties until after Easter."
The statement conveyed the princess' apology for postponing upcoming engagements. It went on to say that the princess is aware that the public will have some interest in her surgery, but hopes people "will understand her desire to maintain as much normality for her children as possible."
The surgery was carried out at The London Clinic, which calls itself the United Kingdom's largest private hospital.
SOURCE: BBC News
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-18 02:15
Read more
- Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura
- Scientists Track Brain Function as Folks Watch Movies
- Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
- Autism Diagnoses Rising Among U.S. Children, Adults
- Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke
- Healthy Eating Index 2015 Score Linked to Overactive Bladder
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions